Drug Topics July/August 2023

Collaboration among faculty, students, national associations, and community pharmacy leaders is crucial as pharmacy practice continues to transform.

Fezolinetant (Veozah) is approved for the treatment of moderate to severe vasomotor symptoms (ie, hot flashes and night sweats) related to menopause.

Despite a wealth of data proving their efficacy for acute and chronic pain, these products remain underutilized in the United States.

Digging deeper into the cause of insomnia and counseling patients on lifestyle changes can help improve their sleep health.

In many industries, tipping is the norm. Pharmacists would just like to receive payment for services rendered.

As the Southern Hemisphere sees a mixed flu season, uncertainty looms for those in the North.

Pharmacists can utilize AI for medication management and to prevent medication errors.

The iLet Bionic Pancreas combines data from the Dexcom G6 CGM with different algorithms to deliver insulin throughout the day.

At least 6 adalimumab biosimilars are set to launch in July 2023.